Navigation Links
Innophos Holdings, Inc. Reports First Quarter 2012 Results
Date:5/1/2012

CRANBURY, N.J., May 1, 2012 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ:   "IPHS"), a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, pharmaceutical, oral care and industrial end markets, today announced its financial results for the first quarter 2012.

First Quarter Results

  • Net sales for the first quarter 2012 were $228 million, a 16% increase over first quarter 2011. 
  • Specialty Phosphates first quarter 2012 sales of $192 million increased 10% compared to first quarter 2011 on higher prices. Specialty Phosphates operating income increased significantly on a sequential basis on improved volumes and margins in the US/Canada business.
  • GTSP & Other sales at $36 million for the 2012 first quarter were $14 million above the year ago level on higher volumes. Lower pricing caused by declining fertilizer market price trends resulted in an operating loss for this segment of $2.5 million; down $6 million versus the prior period.  Early indications for the second quarter are for improving selling prices.
  • As previously reported, during the quarter the company reached a settlement with former parent, Rhodia, on various claims, including a claim for liability for excess water duty charges in Mexico and reduced its estimate on probable amounts to be paid to the Mexican water authority. As a consequence, first quarter 2012 net income included a $7.2 million after tax benefit ($0.32 per share).
  • Net income for the first quarter 2012 was $28 million compared to $26 million for the prior period. Both the first quarter 2012 (as noted above) and the first quarter 2011 benefited from adjustments to expected water duty charges. Excluding these adjustments, net income was $20 million for the first quarter 2012, compared to $24 million for the prior period with the decline attributable exclusively to lower GTSP &
    '/>"/>

    • SOURCE Innophos Holdings, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related biology technology :

    1. Innophos to Present at 2010 Oppenheimer Industrials Conference
    2. China Pharma Holdings, Inc. Will Attend the Susquehanna Financial Group, LLP (SIG) Beijing Management Summit
    3. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
    4. China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40%
    5. China Pharma Holdings, Inc. Appoints The Ruth Group
    6. BioAuthorize Holdings, Inc. Names New Directors and Executive and Unveils Modification to Its Voice Biometric Authentication Service
    7. China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences
    8. China Pharma Holdings, Inc. Receives SFDA Production Approval for Tiopronin Enteric-Coated Capsules
    9. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
    10. JAG Media Holdings, Inc. Announces Letter of Intent for the Acquisition of CardioGenics Inc. by a Wholly-Owned Subsidiary of JAG Media
    11. EFT BioTech Holdings, Inc.s Subsidiary Receives First Permit to Cross Taiwan Strait
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/17/2013)... Tooth decay is an epidemic in American children with ... The World Health Organization says that worldwide, 60–90% ... What are the long-term effects of this transmissible infection? ... the oral bacterial imbalance and serious systemic issues like heart ... is also 100% preventable? Answer: there has been no way ...
    (Date:5/16/2013)... PA (PRWEB) May 16, 2013 Oven ... pid temperature controllers and temperature sensors since 1964. ... widely used in industrial control system applications. ... the device includes a generic, control loop feedback system, ... are expertly used to adjust a systematic process, using ...
    (Date:5/16/2013)... Mass. (PRWEB) May 16, 2013 Cambridge ... Summit from August 19-23, 2013 at the Renaissance Waterfront ... the Summit provide a close-up look at the current ... and ensuring bottom-line quality. Leaders in the field ... ways to produce biopharmaceuticals with greater specificity and efficiency. ...
    (Date:5/16/2013)... -- The registration deadline has been extended until May 22 ... Conference, the premier conference for bioscience financial officers. The ... San Diego Bayfront. "We are putting ... to make sure as many people as possible have ... , Chief Financial Officer of Mast Therapeutics, Inc. ...
    Breaking Biology Technology:Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3New PID Temperature Controllers Announced by Oven Industries Inc. 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4
    ... COPENHAGEN, Denmark and LELYSTAD, Netherlands, March 3, Genmab ... of a research collaboration aimed at identifying fully,human ... those that are difficult to address using,commonly available ... antibodies. These difficulties can for example be due ...
    ... Pathology LIS Interface to Digital Pathology Information ... ... 3 IMPAC Medical,Systems, Inc. (IMPAC), an Elekta company and ... Aperio Technologies, (Aperio) a global leader in digital pathology for,the ...
    ... LONDON, March 3 Amarin Corporation plc,(NASDAQ: ... has signed an exclusive license with,Scarista Limited ... a broad intellectual property portfolio in the ... is complementary to Amarin,s,existing lipid-based development programs ...
    Cached Biology Technology:Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets 2Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets 3IMPAC Medical Systems and Aperio to Develop Integrated Solution for Anatomic Pathology 2IMPAC Medical Systems and Aperio to Develop Integrated Solution for Anatomic Pathology 3Amarin Secures Global Intellectual Property Rights for Lipid Programs 2Amarin Secures Global Intellectual Property Rights for Lipid Programs 3Amarin Secures Global Intellectual Property Rights for Lipid Programs 4
    (Date:5/18/2013)... increasing number of U.S. children are experiencing gastrointestinal ... research presented at Digestive Disease Week (DDW). ... the Cleveland Clinic Children,s Hospital found that obese ... compared to their lean counterparts. The pattern showed ... be correlated to potential complications associated with obesity, ...
    (Date:5/17/2013)... will celebrate the science and technology of the ... during the inaugural Atlanta Science Festival, March 22-29, ... museums, corporations, K-12 schools and universities, the festival ... children and adults at venues across the city. ... The annual Atlanta Science Festival is a collaboration ...
    (Date:5/17/2013)... human-caused climate change may have little impact on ... of recent studies that predict their widespread extinction ... which appear in the journal Global Change ... a creature thought to be doomed: http://onlinelibrary.wiley.com/doi/10.1111/gcb.12253/abstract ... especially forest lizards, will be hard hit by ...
    Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3First Atlanta Science Festival set for 2014 2Climate change may have little impact on tropical lizards 2
    ... China -- The study on single-nucleotide resolution structural variations (SVs) ... Nature Biotechnology . This study was performed ... largest genomics organization in the world, and demonstrates that whole ... for developing a more comprehensive SV map of individuals. ...
    ... A genome-wide association study published in the August issue ... genetic variations that can predict which patients with Hodgkin,s ... years after treatment. Knowing in advance who is at ... risks for patients who are most susceptible to long-term ...
    ... have produced one of the first high-resolution genetic maps ... precise locations across the genome where DNA from a ... a biological process called "recombination." This process results in ... the person,s children. The new map ...
    Cached Biology News:BGI develops new strategy to uncover structural variations of human genomes 2BGI develops new strategy to uncover structural variations of human genomes 32 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma 22 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma 3Life scientists use novel technique to produce genetic map for African Americans 2Life scientists use novel technique to produce genetic map for African Americans 3Life scientists use novel technique to produce genetic map for African Americans 4
    Recombinant Mouse Serpin A1/alpha-1-Antitrypsin, CF Protein Family: Coagulation, Serine Protease Regulators...
    ... hydrophobic plastic supports that retain stiffness in ... solutions. Paper segments on each strip have ... Complementary indicator charts provide clear comparison. Full-range ... units; In packs of 100; each strip ...
    X-prolyl aminopeptidase (aminopeptidase P) 1, soluble...
    This kit only detects beta-galactosidase activity at pH 6 in cultured cells andtissue sections. Beta-galactosidase activity at pH 6 ispresent only in senescent cells, and is not found inpresenescent...
    Biology Products: